Skip to main content
. 2020 Dec 4;10(12):123. doi: 10.1038/s41408-020-00389-w

Fig. 3. Functional interactions between proteins relevant to GC B-cell and DLBCL physiology.

Fig. 3

BCOR BCL6 corepressor; FBXO11 F-box only protein 11; BCL2 B-cell CLL/lymphoma 2; TP53 tumor protein 53; CDKN1A cyclin-dependent kinase inhibitor 1A; CDKN1B cyclin-dependent kinase inhibitor 1B; MEF2B myocyte enhancer factor 2B; BCL6 B-cell CLL/lymphoma 6; PRDM1 PR/SET domain 1; MYC myelocytomatosis; ATM Ataxia telangiectasia mutated; ATR Ataxia telangiectasia and Rad3-related protein; CHEK1 checkpoint kinase 1; MDM2 murine double minute 2; IRF4 interferon regulatory factor 4; AICDA activation-induced cytidine deaminase (Figure prepared using: STRING Protein-Protein Interactions Network (https://string-db.org)).